Help Saba - Cancer Charitable Trust

https://www.bbc.co.uk/news/articles/czek1l0e1w1o?utm_source=firefox-newtab-en-gb

New prostate cancer treatment praised by first recipient at RUH The new high-precision radiotherapy cuts the number of sessions required from 20 to five.

💜 Healing Begins With Support

Every contribution can bring hope, healing, and timely care to cancer patients and their families. Help Saba Cancer Charitable Trust appeals to your kindness to support patients in need with medicines, treatment support, and compassionate care.

Your support today can bring hope and healing tomorrow.
Help before it is too late.

🌐 helpsaba.org
📧 [email protected]
📞 +91 9419688030 | +91 194 4555460
📍 Gure Lane behind Nirman Complex, Barzulla, Srinagar-190005

💚 Together We Care, Together We Cure

United in compassion, driven by hope, and committed to a cancer-free tomorrow. Help Saba Cancer Charitable Trust stands with cancer patients and their families through care, support, awareness, and hope.

Every act of care brings us one step closer to healing. Together, we can support patients, spread strength, and make a meaningful difference in the lives of those fighting cancer.

🌐 www.helpsaba.org
📧 [email protected]
📞 +91 9419688030 | +91 194 4555460

Survivor’s story!

https://www.instagram.com/reel/DTzsYz0kzEv/?igsh=MW5kMGhuY2l4ZXhhMw==

Solutions and hope for people diagnosed with #cancer #cancersurvivor #healing

43-year-old man finds relief after Fortis Gurugram Doctors remove rare giant neck tumour
Vagal schwannomas are exceptionally rare benign nerve sheath tumours arising from the vagus nerve and account for only 2-5% of all head and neck schwannomas.

21 Jun 2026 07:11 IST
author-image
GK NEWS SERVICE
Follow Us
43-year-old man finds relief after Fortis Gurugram Doctors remove rare giant neck tumour
43-year-old man finds relief after Fortis Gurugram Doctors remove rare giant neck tumour

In a remarkable surgical achievement, Doctors at Fortis Memorial Research Institute, Gurugram successfully removed a rare giant 2 kg neck tumour - Vagal Schwannoma, from the neck of a 43-year-old man, restoring his ability to breathe, swallow and sleep normally after 15 years of suffering. The complex surgery was led by Dr Biswajyoti Hazarika, Principal Director, Surgical Oncology and Dr Rudra Sharma, Associate Consultant, Surgical Oncology, who successfully treated the patient and removed the giant tumour.

Vagal schwannomas are exceptionally rare benign nerve sheath tumours arising from the vagus nerve and account for only 2-5% of all head and neck schwannomas. Tumours of this size are particularly uncommon and often pose significant surgical challenges due to their proximity to major blood vessels and critical nerves.

The patient, Raed Majid Mohammed lived with a progressively enlarged swelling on the right side of his neck for nearly 15 years. What began as a small lump gradually developed into a giant tumour that compressed vital structures, including his airway and food pipe, severely affecting his quality of life. Over the last two years, the tumour had grown so large that he could no longer sleep lying down. The moment he reclined, the mass pressed on his airway, creating a choking sensation that forced him to sleep sitting upright, often managing only a few hours of rest each night.

Raed had previously sought treatment at other hospitals, where an attempt to surgically remove the tumour had to be abandoned due to its complexity and close involvement with critical blood vessels and nerves. Seeking a definitive solution, he consulted doctors at Fortis Gurugram. Upon admission at the hospital, detailed imaging and clinical evaluation was done, which revealed a gigantic tumour occupying the entire right side of the neck and extending towards the skull base. Weighing nearly 2 kgs, the mass had significantly distorted the anatomy of the neck and pushed aside major blood vessels.

Recognising the complexity of the case, the Department of Head & Neck Surgical Oncology at Fortis Gurugram, led by Dr. Biswajyoti Hazarika and Dr. Rudra Sharma, assembled a multidisciplinary team comprising Dr. Himanshu Verma, Director, Vascular Surgery, Dr. Balkar Singh and the Anaesthesiology team, along with critical care specialists, nursing staff and rehabilitation experts. During the operation, surgeons encountered a giant 20 × 20-centimetre tumour occupying the entire right side of the neck. The major blood vessels supplying blood to and from the brain were tightly attached to the tumour.

Following the surgery, the patient was monitored closely in the Intensive Care Unit. His recovery was remarkable. On the very first night after surgery, he was able to sleep comfortably in a lying position for the first time in two years. By the third post-operative day, he was swallowing normally, and the visible deformity caused by the tumour had completely disappeared. Giving details of the case, Dr. Biswajyoti Hazarika, Principal Director, Head & Neck Surgical Oncology, Fortis Memorial Research Institute, Gurugram "What makes this case truly special is the transformation in the patient's life after surgery. For years, he struggled with basic activities such as eating, swallowing and sleeping. The tumour had gradually taken away his comfort, confidence and independence. Seeing him sleep peacefully on the very first night after surgery and regain normal swallowing within days was immensely rewarding. Cases like these remind us that beyond removing a tumour, we are restoring dignity, function and hope."

🎗️ Cancer Awareness: Together We Can Fight Cancer

Awareness is the first step toward saving lives. Early detection, timely checkups, and strong community support can make a real difference for cancer patients and their families.

Let’s spread awareness, encourage regular health screenings, and stand with those fighting cancer with hope, care, and compassion.

✅ Know the signs
✅ Get checked early
✅ Support patients and families
✅ Spread hope, save lives

Help Saba Cancer Charitable Trust
Hope • Care • Support

By Hashem Al Ghali
A new pill doubles survival time in patients — the breakthrough has left scientists stunned.

Pancreatic cancer has long been one of medicine's hardest battles — most patients are diagnosed only after the disease has already spread, and treatment options have barely moved the needle in decades. That may finally be changing.

Results from a major clinical trial, presented at the American Society of Clinical Oncology's annual meeting in Chicago, show that a once-daily pill called daraxonrasib roughly doubled survival time for patients with advanced pancreatic cancer, with fewer side-effects than chemotherapy.

The numbers tell the story: in a trial of around 500 patients whose cancer had spread, those taking the pill lived an average of 13.2 months, compared with roughly 6.6 months on standard chemo.

Oncologists who weren't involved in the study have called the results unprecedented, with one veteran specialist admitting she cried in clinic when she read them. ASCO's chief medical officer went further, saying it wasn't just a home run but "a grand slam."

So how does it work? Daraxonrasib targets Kras, a protein that drives the vast majority of pancreatic cancers by telling cells to keep growing and dividing when they shouldn't. The drug essentially grabs and switches off this overactive protein — and crucially, it does so regardless of which Kras mutation a patient has. Researchers say this new class of "Ras(On)" inhibitors could open the door to a wider treatment revolution for a cancer that has resisted progress for far too long.

source:
A. Gregory. The Guardian (2026). “Daily pill can double survival time for world’s deadliest cancer, trial shows.”